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Abstract
Background: There is extensive variation in gene expression among individuals within and between populations. Accurate
measures of the variation in mRNA expression using microarrays can be confounded by technical variation, which includes
variation in RNA isolation procedures, day of hybridization and methods used to amplify and dye label RNA for
hybridization.
Methodology/Principal Findings: In this manuscript we analyze the relationship between the amount of mRNA and the
fluorescent signal from the microarray hybridizations demonstrating that for a wide-range of mRNA concentrations the
fluorescent signal is a linear function of the amount of mRNA. Additionally, the separate isolation, labeling or hybridization
of RNA does not add significant amounts of variation in microarray measures of gene expression. However, single or double
rounds of amplification for labeling do have small but significant affects on 10% of genes, but this source of technical
variation is easy to avoid. To examine both technical and stochastic biological variation, mRNA expression was measured
from the same five individuals over a six-week time course.
Conclusion: There were few, if any, meaningful differences in gene expression among time points. Thus, microarray
measures using standard laboratory procedures can be precise and quantitative and are not subject to significant random
biological noise.
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Introduction
Microarrays simultaneously quantify several hundred to thou-
sands of genes on a single glass slide and their use has greatly
expanded the breadth of quantified gene expression [1–10]. Yet
the preparation of RNA affects the precision of microarray
measures and therefore the ability to accurately quantify the
content of an RNA sample [11]. Additionally, differences in
microarray platforms, laboratory procedures and post-quantifica-
tion analyses affect the precision among arrays [12–15]. Thus,
technical variation can substantially affect the interpretation of
microarrays.
For the teleost fish Fundulus heteroclitus variation among
individuals in mRNA expression is extensive: .60% of genes
have significant differences in expression among individuals within
a population [1,9,16,17]. Many of these differences in gene
expression are associated with variation in cardiac metabolism [9].
However, the accuracy and biological relevance of these
differences in expression depends on the technical variation
inherent to microarray processing [1].
Accurate microarray quantification is best realized when there is
a linear relationship between fluorescence and RNA concentra-
tion. This linear relationship fails when the dynamic range of
microarrays are exceeded. For any microarray, there are two
parameters that define its dynamic range: the range of
fluorescence that can be measured and the range of RNA
concentrations that can bind to a specific array feature. These two
components of the dynamic range reflect the two types of
saturation that can occur on a microarray: photomultiplier tube
(PMT) saturation and biological saturation. A linear relationship
between fluorescence and RNA concentration can only occur if
the cDNA on the microarray captures proportional amounts of
RNA and if the PMT is not saturated.
The PMT measures the number of photons from the
fluorescently labeled RNA that are excited by the lasers. PMT
saturation is a result of the photomultiplier tube becoming
oversaturated due to an overabundance of converted electrons
by the analog to digital (A/D) converter. The A/D converter can
only convert the PMT signal into a value less than or equal to 2
16-
1 or 65,535 and thus any fluorescent photons captured at this
value of 65,535 are not discernable [18]. This type of saturation
can be avoided by reducing the PMT voltage and laser power.
Alternatively, the specific activity of the mRNA (number of
fluorescent molecules per message) can be reduced. However, the
reduction of the PMT voltage, power of the lasers, or reduced
labeling, does not address the question of whether or not a
particular cDNA on a microarray is biologically saturated.
Biological saturation occurs when the amount of mRNA that
can hybridize to the DNA on a microarray reaches a maximum
binding capacity of the printed DNA. If biological saturation is
reached, then the amount of a mRNA will be underestimated and
differences among arrays or experiments can not be appropriately
determined. To avoid biological saturation, the amount of target
RNA must be present in quantities less than the amount that the
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and linear response of increasing amounts of mRNA, we
hybridized a 500-fold concentration range of labeled RNA from
cardiac tissue to the F. heteroclitus 384 cDNA metabolic microarray.
Sources of technical variation, other than PMT and biological
saturation, come from methods used to fluorescently label the
mRNA, the day on which the RNA is processed and varying
amounts of available tissue [19,20]. One of the most common
approaches to fluorescently label mRNA for microarray studies is
to amplify the RNA by synthesizing cDNA with a T7 RNA
polymerase binding site. RNA is then synthesized in vivo by using
the T7 RNA polymerase to incorporate amino allyls followed by
covalent binding of fluorescent molecules to the incorporated
amino allyls [21]. For small amounts of starting mRNA, the
synthesis of RNA using T7 can be repeated to double the
amplification. To understand the effect of a single round versus a
double round of linear amplification we compared the quantifi-
cation of RNA using both methods.
The day and process used to isolate mRNA are two additional
sources of technical variation. Variation in the preparation of
mRNA could alter its quality affecting how well the RNA
amplifies, is fluorescently labeled, and the signal observed on the
microarray. The day on which a tissue is sampled is not strictly
technical but can introduce a second type of variation: biological
variation. That is, isolating tissues on different days could
introduce technical variation because of the precision of dissection
and the quality of tissue or RNA preparation. However, because
tissues are sampled on different days, the organisms may be
biologically different (under more or less stress, healthier, or just
one day older). To examine technical variation due only to RNA
isolation, a single blood sample was divided into four, RNA was
separately isolated from each sample and, gene expression was
quantified. Biological variation was examined in a separate
experiment where five fish were bled every two weeks for a total
of six weeks in order to collect four separate samples from each
individual. Gene expression was quantified for these four
temporally separate samples.
These experiments indicate that for a wide range of experi-
mental conditions, microarray experiments using the Fundulus
array are both accurate and precise.
Materials and Methods
Organism
Fundulus heteroclitus were caught from wild populations in
Wiscasset, Maine, USA (43u579410N, 69u429450W) by minnow
trap. Fish were transported to the Rosenstiel School of Marine and
Atmospheric Science at the University of Miami and acclimated to
20uC and 15ppt for approximately 6 months.
Blood Sampling. Fundulus heteroclitus (N=20) were
anesthetized with MS222 (0.1 g?l
21) and given tags with
subdermal latex markers. Whole blood samples from each fish
were taken every two weeks by caudal puncture using a 50 ml
Hamilton syringe rinsed with heparinzed saline (50 i.u. ?ml
21).
Samples were immediately frozen in liquid N2 and stored at
280uC. Only individuals that had all four serial samples taken
(N=5) were used in the present study.
RNA isolation and amino allyl labeling
Total RNA was isolated using 4.5 M guanidinium thiocyanate,
2% N-lauroylsarcosine, 50 mM EDTA, 25 mM Tris-HCl, 0.1 M
b-Mercaptoethanol and 2% Antifoam A. The extracted RNA was
further purified using a Qiagen RNeasy Mini kit in accordance
with the manufacturer’s protocols. The quantity and quality of the
RNA was determined using a spectrophotometer (Nanodrop, ND-
1000 V3.2.1) and a bioanalyzer (Agilent 2100). RNA was then
converted into amino allyl labeled RNA (aRNA) using the Ambion
Amino Allyl MessageAmp II aRNA Amplification kit. This
method converts poly-A RNA into cDNA with a T7 RNA
polymerase binding site; T7 is then used to synthesize new strands
of RNA (in vitro transcription)[22]. During this in vitro transcription
of aRNA, an amino allyl UTP (aaUTP) is incorporated into the
elongating strand. aaUTP incorporation allows for the coupling of
Cy3 or Cy5 dyes (GE biosciences) onto aRNA for microarray
hybridization.
Dye labeled aRNA aliquots for each hybridization (typically
30 pmol each of Cy3 and Cy5) were vacuum dried together and
resuspended in 15 ml hybridization buffer (final concentration of
each labeled sample=2 pmol/ml). Hybridization buffer consisted
of 56SSPE, 1% SDS, 50% formamide, 1 mg/ml polyA, 1 mg/ml
sheared herring sperm carrier DNA, and 1 mg/ml BSA. Slides
were washed in sodium borohydride solution in order to reduce
autofluorescence. Following rinsing, slides were boiled for
2 minutes and spin-dried in a centrifuge at 800 rpm for 3 minutes.
Samples (15 ml) were heated to 90uC for 2 minutes, quick cooled
to 42uC, applied to the slide (hybridization zone area was
350 mm
2), and covered with a cover slip. Slides were placed in
an airtight chamber humidified with paper soaked in 56 SSPE
and incubated 24–48 hours at 42uC.
Microarrays
mRNA expression was measured using microarrays where each
array had four spatially separated replicates per gene. The 384 F.
heteroclitus cDNA microarrays were printed using 55 control genes
and 329 cDNAs which encode essential proteins for cellular
metabolism (Table 1). The annotation of genes and related
pathways used FunnyBase [23] and these were manually compared
to KEGG pathway designations. Because many genes belong to
more than one pathway, central metabolic pathways were
preferentially used if the gene coded for a protein that was a
catabolic or anabolic enzyme (versus acting in a signaling pathway
that affected metabolism). Controls include DNA spots labeled
with Cy5 (positive control for position and gridding) and Ctenophore
cDNA as negative controls.
Microarrays were created by printing cDNAs amplified with
amine-linked primers onto 3-D Link Activated slides (Surmodics
Inc., Eden Prairie, MN) at the University of Miami’s microarray
facility. All printed cDNAs were re-sequenced from the same
source used for printing. The microarray slides were scanned using
ScanArray Express. The raw TIFF-image data was quantified
using Imagene (v5).
All experiments used a loop design for hybridization of dye
labeled aRNA [24,25]. In a loop design [24,25] each individual is
labeled with Cy3 and Cy5. Each dye labeled sample is then
hybridized on different arrays with another individual [26]. Thus,
each individual is hybridized to two arrays with four replicates per
array for a total of eight technical replicates per individual. This
experimental design is a more efficient use of resources, providing
more data per array and is thus statistically more powerful than a
reference design.
To test for the relationship between fluorescence and the
quantity of RNA, five concentrations of fluorescently labeled RNA
were used: 1.2 to 700 pmol of Cy3 or Cy5 labeled mRNA where
pmol are for the amount of incorporated dye (Table 2). A 15 ml
hybridization using the 384 cDNA array corresponds to 0.09 to
47 mM of Cy dye. Cy5 dye labeled RNA was used at
concentrations 18% less than Cy3 because the Cy5 dye is a more
efficient fluorophore (greater fluorescence per photon) than the
Microarray Variation
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was normalized to the original concentration of RNA added.
Criteria for Inclusion
For a gene to be included in an analysis, the average signal
among all arrays and dyes had to exceed background but not
exceed 95% of PMT saturation (65,535). Background signal was
determined as the amount of fluorescence in negative control
array elements. Not all genes met these criteria and therefore were
not included in the analysis.
Statistics
To adjust for systematic variation, gene expression values were
first sum normalized, log2 transformed, and then loess normalized
using Microarray Data Analysis System Software (MIDAS) [12,27]
and SAS JMP Genomics v.6.0.2. For every gene, eight fluorescence
values werecaptured;four Cy3 values and four Cy5 values. Analysis
of variance (ANOVA) was performed using SAS JMP Genomics
v.6.0.2. To look for differences between single and double rounds of
amplification the following ANOVA model was applied: yijkl=
m+Ai+Dj+k+Rl+eijklwheremisthesamplemean,Aiistheeffect ofthe
i
th array (i=1–18), Dj is the effect of the j
th dye (Cy3 or Cy5), Tk is
the effect of the number of rounds of amplification (single or double,
k=2), Rl is the effect of the day on which samples were prepared
(l=3), and epsilon is stochastic effects. The number of rounds of
amplification (single or double) and channel variables were treated
as fixed effects and array, and day on which samples were prepared
weretreatedas random effects. Statistical analyses of replicate blood
samples or repetitive measures of the same five individuals were
applied to a separate ANOVA for each individual. The ANOVA
model for this comparison was as follows: ymnp=m+Am+Dn+Tp+emnp
where m is the sample mean, Am is the effect of the m
th array (m=1–
4 for both replicate and repetitive samples), Dn is the effect of the n
th
dye (Cy3 or Cy5), Tp is the treatment effect and epsilon is stochastic
effects. Sample, representative of either one of four temporal
samples from an individual or one of four replicate blood samples,
and channel were treated as fixed effects. Array was treated as a
random effect. Significant differences were evaluated with a p-value
cut-off of 0.01.
Results
Biosaturation
The concentration of fluorescently labeled RNA (0.09 to 47 mM
of Cy dye) represents 0.16,1 6,5 6,1 0 6,5 0 6the concentration
of RNA typically used on F. heteroclitus cDNA microarrays
[9,26,28–30] (Table 2, MIAME GSE12858). Among the 329
metabolic genes on the array, 212 of these genes met our criteria of
being less than 95% of the PMT saturation and more than two
standard deviations above the negative controls (Ctenophore cDNA
with no similarity to vertebrate genes).
The linear relationship between the amount of RNA and
relative fluorescence is shown in Figure 1. To remove the gene
specific differences in expression, the fluorescence at each
concentration was divided by the mean fluorescence for that
specific gene (Fig. 1). The linear relationship between the amount
of total fluorescent RNA added and the measures of gene specific
fluorescence was determined for each gene. Most genes (176/212
or 83%) had an R
2.95% and 78 genes had a nearly perfect R
2
(.0.995; Fig. 1B; Table 3). Examining the 18 genes with the
lowest R
2 values (less than 0.8) revealed a non-linear relationship
that can be explained by an apparent saturation at the 506
concentration of RNA (Fig. 1C). The relationship disappears if the
fluorescence values for the 506 concentrations of RNA are
removed and the 0.1 to 106are plotted (Fig 1D–F). In the 100-
fold range (0.1 to 106) only three genes (1.4%) had R
2 values less
than 0.8 (Table 3). Examination of the higher concentrations (1.0
to 506) revealed 19 genes (9%) with R
2 less than 0.8 (Table 3).
These data suggest that for most genes there is a linear relationship
for a 500-fold range of RNA, however some cDNAs on the
microarray will reach biological saturation at the highest RNA
concentration.
Variation in RNA preparation
To determine how RNA preparation affects variation, cardiac
RNA from three individuals were combined, and then evenly
divided and amino allyl and dye labeled on three separate days
using single and double rounds of amplification (MIAME,
GSE12858). Only 110 genes met our criteria for inclusion because
many genes were below the low cut-off (Ctenophore negative control
cDNAs). In this experiment fewer genes met our criteria of above
background and below saturation due to sample RNA being
Table 1. 384 Array Metabolic Pathways.
Amino acid metabolism 28
ATP synthesis 27
Blood group glycolipid biosynthesis 3
Channel 3
Citrate cycle (TCA cycle) 24
Fatty acid metabolism/transport 36
Fructose and mannose metabolism 4
Galactose metabolism 2
Glutamate metabolism 7
Glutathione metabolism 10
Glycerolipid metabolism 7
Glycolysis/Gluconeogenesis 27
Inositol phosphate metabolism 14
Ox-Phos-ATPsyn 64
Pentose phosphate pathway 6
Purine & Pyrimidine metabolism 9
Pyruvate metabolism 2
Signaling pathway 10
Starch and sucrose metabolism 2
Sterol biosynthesis 8
Synthesis and degrad. of ketone bodies 4
Tetrachloroethene degradation 3
Secondary 27
TOTAL METABOLIC GENES 329
doi:10.1371/journal.pone.0004486.t001
Table 2. Concentrations of Cy3 and Cy5 dye labeled RNA
used for hybridization.
506 106 56 16 .16
Cy 3 700 pmol 140 pmol 70 pmol 14 pmol 1.4 pmol
Cy 5 583.3 pmol 116.6 pmol 58.3 pmol 11.6 pmol 1.2 pmol
doi:10.1371/journal.pone.0004486.t002
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of amplification. An ANOVA was performed to measure
differences between single and double rounds of amino allyl
labeled RNA amplification. Twelve of the 110 genes (11%) used in
this analysis were significantly different between single and double
rounds of amplification at p,0.01. The majority of genes (59%)
had a higher fluorescence signal when only one round of
amplification was performed.
Consistency of Quantitative Determination
In teleost fish, red blood cell (RBCs) nuclei are transcriptionally
active [31,32], and these cells can be sampled without sacrificing
the fish. Thus to assess the consistency of microarray determina-
tions, two experiments were performed on blood gene expression:
1) to examine technical variation a single sample of blood was
divided into four samples; RNA isolations, amino allyl and dye
labeling, hybridization and quantitative analyses were performed
on each sample and 2) to examine biological variation, RNA
isolated from blood from the five individuals were each sampled
four times over a 6 week period (two weeks between samples;
MIAME, TBA).
Figure 1. Linear relationship of RNA concentration to relative fluorescence. Graphs show linear relationship between concentrations of
RNA (0.1–506, A–C, and 0.1–106, D–F) and relative fluorescence. Relative fluorescence is a normalized measure of fluorescence divided by the gene
specific mean. 16RNA is equal to 0.9 pmol/ml. Shown are the RNA concentrations versus fluorescence for 0.1 to 506(A–C) and for 0.16to 106(D–F);
for all genes (A and D), for the 78 genes with the highest R
2 values (B and E), and for the 18 with lowest R
2 values (C and F).
doi:10.1371/journal.pone.0004486.g001
Table 3. Number of genes and corresponding R
2 for various
ranges of RNA concentrations.
R
2 0.1–506 0.1–106 1.0–506
.0.9 176 199 178
,0.8 18 3 19
doi:10.1371/journal.pone.0004486.t003
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in gene expression between the four RNA samples isolated from a
single blood sample (Fig. 2). Among all 252 genes (eight replicates
per gene per sample) only 6 genes were significantly different for
the four isolates at a critical p-value of 0.01. Three false-positives
are expected at a p-value of 0.01 and thus with only 6 significant
differences (Fig. 2) there is little evidence that separate RNA
isolation, labeling and hybridization has much affect on measures
of gene expression. The lack of differences is not due to high
technical variation: CV (standard deviation/mean) among the
eight replicates was 4% and, only three genes had a CV of .10%.
Nor was it due to the low p-value of 0.01 versus 0.05 (Fig. 2); the
number of significant differences simply reflects the p-values.
Random biological variation can contribute to differences in
expression. We tested for random biological variation by bleeding
the same five individuals four times with two weeks between
bleedings (Fig. 3, MIAME, TBA). For each of the 304 genes that
met our criteria, an ANOVA tested for differences in expression
among the four different time periods for each individual (four
sample periods with eight replicates per gene per sample period).
Among the four temporal samples, there were between one and
seven genes that had a significant difference in expression at a p-
value of 0.01 (Fig. 3). Only one individual had more than the
expected number of false positives at the critical p-value:
individual-00 had 7 (2%) significant genes at p-value 0.01 for
304 genes.
Discussion
Understanding sources of variation in gene expression is important
for determining the biological importance of measured differences in
mRNA expression. The analyses of technical variation in the
metabolic F. heteroclitus cDNA microarray suggest that measures of
gene expression using the F. heteroclitus 384 cDNA microarray are
quantitative and precise. This conclusion is based on the observation
that there is a linear increase in fluorescence with increasing mRNA
(Fig. 1), and that there is little additional variation due to RNA
processing (Fig. 2) or the day on which RNA is isolated (Fig. 3).
There is a linear increase in fluorescence with increasing mRNA
for 98.5% of genes between 0.16 to 106 concentrations
(0.09 pmol/ul to 9.3 pmol/ul) and 95% of genes between 0.16
to 506 (0.09 pmol/ul to 47 pmol/ul). The linear relationship
between RNA and fluorescence is quite strong for RNA
concentrations of 0.16 to 106 having average R
2 values of
0.97, and most genes (88%) have R
2 values greater than 0.95 for
these four concentrations. The genes most affected by biological
saturation do not have a high fluorescence; if anything, they are
less than the average (genes with R
2,0.8 for 16 to 506 have a
mean that is 60% of the mean for all other genes). The two
possible explanations for biological saturation with low fluores-
cence are that the synthesis of amino allyl labeled RNA for these
genes is strongly truncated or that there is less DNA printed on the
array for these genes. Truncation of amino allyl labeling would
Figure 2. Gene expression for Single Blood isolate. Heat map for single blood isolate that was divided into four. RNA was purified, labeled and
hybridized separately for each sample. Red is greater and green is less than the average gene specific fluorescence. First column (P) is the p-value
from a one-way ANOVA. Only 6 genes (2.3%) out of 252 are significant at a critical p-value of 0.01. P-values (2log10) shown in the heat map are from
an ANOVA for significant differences among samples using the 8 replicates for each separate RNA isolation. Color bar gives fold difference for log2
gene expression (e.g., 2=46) and negative log10 p-value (e.g., 2=p-value of 0.01).
doi:10.1371/journal.pone.0004486.g002
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to produce a similar fluorescence many more molecules would be
necessary and these would saturate the DNA on the array. These
problems can be avoided by using moderate amounts of probe
(,10 pmol/ul). We typically avoid this problem by using 0.7 to
2 pmol/ul. Using concentrations of RNA up to 506(47 pmol/ul)
is feasible, but our data suggest that at this high of a concentration
some genes will biologically saturate the cDNA on the array and
therefore should be avoided.
If RNA samples are amino allyl labeled using one round of T7-
RNA synthesis [22] versus two rounds of T7-RNA synthesis, 11%
of genes have significant differences in fluorescence at a p-value of
0.01. Although this difference in gene expression for single versus
double labeling is not large, it may be unacceptably high. Thus, we
would suggest that for any one experiment that a researcher uses
only single or double labeling procedures but not both within an
individual experiment. Approximately half (59%) of genes with a
significant difference between single and double labeling were
greater for single labeling. The greater fluorescence for single
labeling than that for double labeling would occur if cDNA or
RNA synthesis was truncated with each round of labeling.
Truncation would occur if the synthesis of cDNA or RNA were
incomplete forming shorter nucleotide sequences with less
fluorescence per RNA.
We used blood to test the effect of different RNA isolations,
amino allyl labeling and hybridizations. The first experiment used
a single blood isolation that was divided into four equal samples.
There are few differences in expression, 2.4% at a p-value of 0.01
(i.e., six versus the expected three false positives). If a Bonferroni
correction was applied none of these genes would be significant.
Therefore, technical errors do not necessarily contribute signifi-
cant amounts of variation. Similar conclusions were made about
microarray results among laboratories: many different laboratories
yielded similar results using different varieties of platforms [13–
15,33–36]. However, a few laboratories yielded different results.
Together these data suggest that good experimental practice can
minimize the effect of technical variation.
In a separate experiment, five individuals were bled once every
two weeks during a six-week period, resulting in four serial blood
samples from each individual. Any differences in expression
among sampling times could be due to technical variation, of
which there is very little as shown by the previous experiment, or
biological variation. That is, although fish appeared healthy, had
normal blood glucose, and the stress hormone, cortisol, did not
vary significantly (p.0.1), gene expression could vary significantly
for unknown biological reasons. Yet, for the five individuals there
are few, if any, meaningful differences in gene expression (only one
individual had more than the expected number of false positives,
Fig. 3). These data confirm the observation that technical errors do
not necessarily affect microarray measures. Importantly, these
data also suggest that for a tissue or blood sample there is little
random stochastic variation in gene expression. These data are in
Figure 3. Individuals sampled over time. Heat map for one individual (00) sampled 4 times over a total of 6 weeks. Numbers above the heat
map are time points (0, 2, 4 & 6 weeks) and the ‘‘P’’ is for p-value (2log10). P-values are from the ANOVA that tested for differences among separate
blood isolations within an individual (4 isolations and 8 replicates per isolation). For gene expression, red is greater and green is lower expression
than the mean expression for each gene. Table provides number of significant genes and percent (rounded up) out of the total of 304. Color bar gives
fold difference for log2 gene expression (e.g., 2=46) and negative log10 p-value (e.g., 2=p-value of 0.01).
doi:10.1371/journal.pone.0004486.g003
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noisy and has large stochastic variation [37,38]. The important
distinction is that for a single cell, transcription is pulsatile,
occurring in bursts [37,38], and for an individual cell this creates
large stochastic variation in mRNA expression. However, our
results demonstrate that for millions of cells, this variation is not
apparent across a 6-week time course. We suggest that if there is a
large stochastic variation in each cell, sampling of millions of cells
masks this variation such that the amount of expression from any
one gene is stable over time.
The microarrays used here have array elements for essential
metabolic genes (Table 1) and are similar to the array elements
used in previous work demonstrating larger inter-individual
variation in gene expression [1,9,16,17]. While the data presented
here addresses the sources of variation in many microarray
experiments, the lack of temporal variation in gene expression in
our study may only reflect the expression of the metabolic genes.
However, these results are similar to studies of gene expression in
humans where the same individuals were sampled over a time
period of 24 hours to four weeks [39–41]. These studies also found
relative stable expression of a more diverse set of genes when the
same individuals were sampled over time. Thus, although there
are good biochemical or molecular reasons to expect stochastic
variation in gene expression, this variation is not necessarily
observed using routine sampling methods.
Microarrays are a useful technology for observing differences in
gene expression and data extracted from microarrays can be
reliably reproduced. With reasonable care, any experiment
involving microarrays is capable of obtaining biological data that
is not masked by technical variation thereby providing a true
representation of the transcriptome under a particular set of
conditions. However, caution is required before making conclu-
sions about the biological nature of the data until the sources of
technical variation are understood.
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